Search

everythinglearnresearchcommunity

for

Search:↓

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

BMP signaling controls hair growth and skin color.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

A mother's western diet can make her milk toxic, causing inflammation and hair loss in babies.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.